Literature DB >> 6481162

Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.

J E Salmon, R P Kimberly, A Gibofsky, M Fotino.   

Abstract

Fc receptor-mediated mononuclear phagocyte system (MPS) clearance is impaired in systemic lupus erythematosus (SLE) and may contribute to the pathogenesis of the immune complex disease. To investigate the basis of MPS dysfunction, we have examined concurrent in vivo and in vitro Fc receptor function in 22 patients with SLE and 23 disease-free adults. Blood monocyte Fc receptor binding was increased rather than decreased as predicted by the saturation hypothesis of MPS blockade. Rosette formation of IgG-sensitized bovine erythrocytes (EA) with monocytes demonstrated increased Fc receptor-ligand binding in SLE (percent rosettes: 40 +/- 12 vs 27 +/- 8, p less than 0.001). Scatchard analysis of the binding of radiolabeled IgG oligomers to SLE monocytes indicated a mean receptor number 30% higher than control, although this did not reach statistical significance. Despite enhanced Fc receptor-ligand (EA) binding, Fc-mediated phagocytosis of EA was decreased in SLE (1.7 +/- 0.7 erythrocytes/monocytes/hour vs 2.6 +/- 1.0, p less than 0.004). This decrease in phagocytosis by blood monocytes from SLE patients was significantly greater than that attributable to the predominance in SLE of individuals with certain HLA B cell alloantigens and intrinsically lower phagocytic rates (p less than 0.05 for all groups). This decrease therefore represents a disease-acquired characteristic. Furthermore, the phagocytic rate of the four SLE patients with marked prolongation in MPS clearance was significantly lower than that of the eight patients with near normal clearance values (p less than 0.01). Saturation of Fc receptors by immune complexes does not explain impaired immune clearance in SLE. Our results indicate that despite increased binding of the EA ligand, Fc receptor-mediated phagocytosis is markedly impaired in SLE monocytes. This impairment cannot be explained on the basis of HLA-related differences in phagocytosis among lupus patients. The defect in phagocytosis of EA is most profound in those patients with the most significantly impaired MPS clearance. Thus, the dissociation of receptor-ligand binding and receptor-mediated internalization may contribute significantly to the in vivo clearance defect in SLE.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481162

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance.

Authors:  Susanne Kuenkele; Thomas D Beyer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

Review 2.  Fcgamma receptors: structure, function and role as genetic risk factors in SLE.

Authors:  X Li; T S Ptacek; E E Brown; J C Edberg
Journal:  Genes Immun       Date:  2009-05-07       Impact factor: 2.676

3.  Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells.

Authors:  G Herrero-Beaumont; J Egido; J Sancho; E González; S Castañeda; J F Escanero
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

4.  [An impaired detection and clearance of dying cells can lead to the development of chronic autoimmunity].

Authors:  L E Munoz; M Herrmann; U S Gaipl
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

5.  Overwhelming pneumococcal bacteraemia in systemic lupus erythematosus.

Authors:  D Petros; S West
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

6.  Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects.

Authors:  J L Ceuppens; M L Baroja; F Van Vaeck; C L Anderson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 7.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

8.  Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms.

Authors:  K Manger; R Repp; M Jansen; M Geisselbrecht; R Wassmuth; N A C Westerdaal; A Pfahlberg; B Manger; J R Kalden; J G J van de Winkel
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

9.  Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus.

Authors:  E Gyimesi; M Kavai; E Kiss; I Csipö; G Szücs; G Szegedi
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 10.  Diagnosis and management of infectious complications of childhood rheumatic diseases.

Authors:  Rhina D Castillo; Wendy De la Pena; Katherine A B Marzan
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.